Therapeutic Frontiers in Managing Spinal Muscular Atrophy Type 1
The thrust of medical progress in treating SMA type 1 is now to bring it into the realm of rare but manageable diseases.
SMA Insights
SMA Biomarkers as Gateways to Better Clinical Care
Through the combined efforts of researchers, key biomarkers of spinal muscular atrophy have been identified.
Breaking Down the Genetics of SMA to Develop Treatment Options
Researchers conducted a review of what we know about SMA genetics and how that impacts the development of genetic therapies.
Carrier Screening for Autosomal Recessive and X-Linked Conditions
Medicine as it is understood today is an umbrella term that covers the detection, diagnosis, management, and prevention of disease. It is, rightly so, akin to a broad kitchen in which there can never be too many cooks. As physicians debate how best to treat genetic rare diseases, (such as Duchenne muscular dystrophy, spinal muscular…
Managing Spinal Muscular Atrophy: Recent Clinical Insights
Several pieces of recently published research may aid clinicians in managing spinal muscular atrophy (SMA) across the life span. Review highlights of some of the studies below. Early Treatment for Preterm Infants With SMA SMA is being diagnosed earlier than ever before, even before symptoms arise. For preterm infants who do not yet demonstrate SMA…
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Insights
Loading... 
Loading...